help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagamani, M.
Right arrow Articles by Kelver, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagamani, M.
Right arrow Articles by Kelver, M. E.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 5 1685-1689
Copyright © 1999 by The Endocrine Society


From the Clinical Research Centers

Increased Bioactive Luteinizing Hormone Levels and Bio/Immuno Ratio in Women with Hyperthecosis of the Ovaries: Possible Role of Hyperinsulinemia1

Manubai Nagamani, Collins Osuampke and Mae Ellen Kelver

Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, University of Texas Medical Branch, Galveston, Texas 77555-0587

Address all correspondence and requests for reprints to: Manubai Nagamani, M.D., Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77555-0587. E-mail: mnagaman{at}utmb.edu

Unlike women with polycystic ovarian disease, women with hyperthecosis have normal or low immunoactive LH levels. They have severe insulin resistance with marked hyperinsulinemia. Bioactive LH levels have not been studied in these women. The purpose of this study was to investigate 1) whether there is an increase in bioactive LH levels in women with hyperthecosis of the ovaries and 2) whether hyperinsulinemia has an effect on LH secretion. Six women with hyperthecosis of the ovaries confirmed by histological examination were included in the study. Six normal women in the midproliferative phase of the cycle served as controls. All women were admitted to the Clinical Research Center at 0800 h, and blood samples were obtained every 15 min for 6 h. All samples were assayed for LH by RIA and bioassay. The PC Pulsar Program was used for pulse analysis of LH secretion. Patients with hyperthecosis had significantly higher (P < 0.002) bioactive LH levels (66.9 ± 13 mIU/mL) than controls (29.3 ± 6 mIU/mL). Immunoactive LH levels in hyperthecosis were not significantly different from those in control women. Significantly higher bio/immuno LH ratios (P < 0.001) were observed in women with hyperthecosis (6.2 ± 0.9) than in normal control women (2.4 ± 0.5). There was a significant positive correlation between insulin levels and the bio/immuno ratio of LH. Pulse amplitude and interpulse intervals for immunoactive LH in hyperthecosis patients were similar to those in control women. The pulse amplitude of bioactive LH was significantly higher (P < 0.01) in women with hyperthecosis compared to that in normal controls. Hyperinsulinemia induced during LH sampling resulted in increased bioactive LH levels with no change in immunoactive LH. These results indicate that 1) women with hyperthecosis of the ovaries have increased secretion of biologically active LH, and 2) hyperinsulinemia may enhance the secretion of the biologically active form of LH.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. Piaditis, A. Angellou, G. Kontogeorgos, N. Mazarakis, T. Kounadi, G. Kaltsas, K. Vamvakidis, R. V. Lloyd, E. Horvath, and K. Kovacs
Ectopic Bioactive Luteinizing Hormone Secretion by a Pancreatic Endocrine Tumor, Manifested as Luteinized Granulosa-Thecal Cell Tumor of the Ovaries
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2097 - 2103.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Bergendah and J. D. Veldhuis
Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: III. Luteinizing hormone heterogeneity: a medical physiologist's perspective
Hum. Reprod., June 1, 2001; 16(6): 1058 - 1064.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. W. Speiser, M. Susin, H. Sasano, S. Bohrer, and J. Markowitz
Ovarian Hyperthecosis in the Setting of Portal Hypertension
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 873 - 877.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society